Chancellor Financial Group WB’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Chancellor Financial Group WB's BMY Position: Q2 2026 in Review
Chancellor Financial Group WB increased its Bristol-Myers Squibb (BMY) stake by 1.9% in Q2 2026, buying an estimated $6.14K and bringing the position to 5,792 shares worth $334K. The position accounts for 0.21% of the portfolio, ranked #101.
Chancellor Financial Group WB first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $592K in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Chancellor Financial Group WB held 5,792 shares of Bristol-Myers Squibb worth $334K as of Q2 2026.
- Chancellor Financial Group WB bought 107 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.14K.
- Bristol-Myers Squibb made up 0.21% of Chancellor Financial Group WB's portfolio in Q2 2026, its #101 holding.
- Chancellor Financial Group WB first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Chancellor Financial Group WB's Bristol-Myers Squibb position peaked at $592K in Q4 2025.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Chancellor Financial Group WB's 13F filing for Q2 2026, filed 10 Aug 2026.